Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Based on the decline in postings

Based on the decline in postings

posted on Apr 08, 2010 02:37PM
on the PTSC message boards, I would venture to guess that there are just not as many people holding this stock any longer. I don't think that Swartz is a problem any longer--so, with him not selling and fewer shareholders involved, I don't anticipate the large sell-offs that we had years ago. I remember the dividend announcement causing a rather large spike in s/p--if they decide to do that again, I think that we may have a very good response esp. since Swartz won't be in the picture. Good news from the USPTO could start the ball rolling--IF we ever get it. GL, ads
Share
New Message
Please login to post a reply